Cantor Fitzgerald Initiates Coverage On Electra Therapeutics with Overweight Rating
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsInitiation
Cantor Fitzgerald analyst Eric Schmidt initiates coverage on Electra Therapeutics (NASDAQ:ETRA) with a Overweight rating.
Cantor Fitzgerald analyst Eric Schmidt initiates coverage on Electra Therapeutics (NASDAQ:ETRA) with a Overweight rating.